In the review article authors describe changes in the indication of the intervention in patients with severe symptomatic
aortic stenosis since 2007 when transcatheter implantation of the aortic bioprosthesis received CE until 2017
when the latest Guidelines of the European Society of Cardiology and European Association for Cardio-Thoracic
Surgeons were published. They describe the status and future of transcatheter aortic bioprosthesis implantation.
They also delineate the status of transcatheter aortic bioprosthesis implantation in Slovakia.